The estimated Net Worth of Vered Caplan is at least $1.75 Million dollars as of 28 January 2022. Ms. Caplan owns over 278,191 units of Orgenesis Inc stock worth over $171,922 and over the last 12 years she sold ORGS stock worth over $0. In addition, she makes $1,577,660 as Chairperson of the Board of Directors and Chief Executive Officer at Orgenesis Inc.
Sign up
Ms. Caplan ORGS stock SEC Form 4 insiders trading
Vered has made over 1 trades of the Orgenesis Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently she exercised 278,191 units of ORGS stock worth $2,782 on 28 January 2022.
The largest trade she's ever made was exercising 278,191 units of Orgenesis Inc stock on 28 January 2022 worth over $2,782. On average, Vered trades about 30,910 units every 0 days since 2012. As of 28 January 2022 she still owns at least 278,191 units of Orgenesis Inc stock.
You can see the complete history of Ms. Caplan stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Vered Caplan biography
Vered Caplan serves as Chairperson of the Board of Directors, Chief Executive Officer of the Company. of the Company. of the Company. of the Company. Vered Caplan was appointed President and CEO on August 14, 2014, prior to which she was Interim President and CEO since December 23, 2013. Since 2008, Ms. Caplan has been Chief Executive Officer of Kamedis, a company focused on utilizing plant extracts for dermatology purposes. From 2004 to 2007, Ms. Caplan was Chief Executive Officer of GammaCan, a company focused on the use of immunoglobulins for treatment of cancer. During the previous five years, Ms. Caplan has been a director of the following companies: Opticul Ltd., a company involved with optic based bacteria classification; Inmotion Ltd., a company involved with selfpropelled disposable colonoscopies; Nehora Photonics Ltd., a company involved with noninvasive blood monitoring; Ocure Ltd., a company involved with wound management; Eve Medical Ltd., a company involved with hormone therapy for Menopause and PMS; and Biotech Investment Corp., a company involved with prostate cancer diagnostics. Ms. Caplan has a M.Sc. in biomedical engineering from TelAviv University specializing in signal processing; management for engineers from TelAviv University specializing in business development; and a B.Sc. in mechanical engineering from the Technion specialized in software and cad systems.
What is the salary of Vered Caplan?
As the Chairperson of the Board of Directors and Chief Executive Officer of Orgenesis Inc, the total compensation of Vered Caplan at Orgenesis Inc is $1,577,660. There are no executives at Orgenesis Inc getting paid more.
How old is Vered Caplan?
Vered Caplan is 52, she's been the Chairperson of the Board of Directors and Chief Executive Officer of Orgenesis Inc since 2019. There are 5 older and 5 younger executives at Orgenesis Inc. The oldest executive at Orgenesis Inc is Prof. Sarah Ferber Ph.D., 67, who is the Founder & Chief Scientific Officer.
What's Vered Caplan's mailing address?
Vered's mailing address filed with the SEC is 20271 GOLDENROD LANE, , GERMANTOWN,, MD, 20876.
Insiders trading at Orgenesis Inc
Over the last 12 years, insiders at Orgenesis Inc have traded over $4,872,134 worth of Orgenesis Inc stock and bought 375,420 units worth $216,187 . The most active insiders traders include Sca Theodorus, Ii Sa Theodorus, and Olivier Belenger. On average, Orgenesis Inc executives and independent directors trade stock every 263 days with the average trade being worth of $1,118,704. The most recent stock trade was executed by Victor Miller on 1 April 2024, trading 25,000 units of ORGS stock currently worth $12,500.
What does Orgenesis Inc do?
orgenesis inc (orgs) is a medical device company located in 21 sparrow cir, white plains, new york, united states.
What does Orgenesis Inc's logo look like?
Complete history of Ms. Caplan stock trades at Orgenesis Inc
Orgenesis Inc executives and stock owners
Orgenesis Inc executives and other stock owners filed with the SEC include:
-
Vered Caplan,
Chairperson of the Board of Directors, Chief Executive Officer -
Vered Caplan M.Sc.,
Chairperson of the Board, CEO & Pres -
Darren Head,
Chief Executive Officer of Masthercell Global -
Neil T. Reithinger CPA,
CFO, Sec. & Treasurer -
Denis Bedoret,
President of Masthercell Global -
Sarah Ferber,
Chief Scientific Officer -
Neil Reithinger,
Chief Financial Officer, Treasurer, Secretary -
David Sidransky,
Independent Director -
Guy Yachin,
Independent Director -
Yaron Adler,
Independent Director -
Ashish Nanda,
Independent Director -
Mario Philips,
Independent Director -
Vincent Vandamme,
Sr. VP of Quality Strategy -
Lilach Harel,
VP of Global HR -
Osher Partok Rheinisch,
Gen. Counsel & Compliance Officer -
Dr. Shimon Hassin Ph.D.,
Chief Technology Officer -
Joseph Green,
Chief Operating Officer -
Evan Fishman,
Chief Financial Officer -
Prof. Sarah Ferber Ph.D.,
Founder & Chief Scientific Officer -
Elliot Maltz,
Chief Financial Officer -
Olivier Belenger,
-
Hugues Bultot,
Director -
Libre De Bruxelles Universite,
-
Ii Sa Theodorus,
-
Sca Theodorus,
-
Etti Hanochi,
Director -
Itzhak Vider,
Director -
Victor Miller,
CHIEF FINANCIAL OFFICER -
Jacob Safier,
10% owner -
Mark Goodman,
Director -
Kunik Efrat Assa,
Chief Development Officer